The use of amisulpride in the treatment of acute psychosis
about
Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorderUpdate on the management of symptoms in schizophrenia: focus on amisulpride.Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review.A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.Prandial effect on the systemic exposure of amisulpride.
P2860
The use of amisulpride in the treatment of acute psychosis
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The use of amisulpride in the treatment of acute psychosis
@ast
The use of amisulpride in the treatment of acute psychosis
@en
The use of amisulpride in the treatment of acute psychosis
@nl
type
label
The use of amisulpride in the treatment of acute psychosis
@ast
The use of amisulpride in the treatment of acute psychosis
@en
The use of amisulpride in the treatment of acute psychosis
@nl
prefLabel
The use of amisulpride in the treatment of acute psychosis
@ast
The use of amisulpride in the treatment of acute psychosis
@en
The use of amisulpride in the treatment of acute psychosis
@nl
P2093
P2860
P356
P1476
The use of amisulpride in the treatment of acute psychosis
@en
P2093
Cédric Tessier
Martina Hummer
Philippe Nuss
P2860
P356
10.2147/TCRM.2007.3.1.3
P407
P577
2007-03-01T00:00:00Z